CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net loss	$ (71,735)	$ (40,116)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,821	3,671
Equity-based compensation	21,838	26,501
Change in fair value of warrant liability	4,101	(24,675)
Realized and unrealized gain on marketable securities	(546)	(72)
Equity method investment loss	191	230
Asset retirement obligation accretion	66	56
Amortization of debt issuance costs and discount	3,151
Changes in operating assets and liabilities:
Accounts receivables	(164)	(428)
Other current assets	537	593
Other assets	119	161
Accounts payable	(627)	486
Deferred revenue	202	(1,537)
Accrued expenses and other liabilities	1,884	(2,501)
Operating lease right-of-use assets and liabilities	722	536
Net cash used in operating activities	(35,440)	(37,095)
Investing activities
Capitalization of costs and purchases of network assets, property, and equipment	(2,751)	(2,964)
Purchase of equity method investments		(1,125)
Purchase of marketable securities	(37,441)	(13,644)
Sale and maturity of marketable securities	42,249	5,500
Purchase of business, net of cash acquired		(2,890)
Purchase of internal use software	(983)	(613)
Net cash provided (used in) investing activities	1,074	(15,736)
Financing activities
Proceeds from debt	70,000
Payments towards debt issuance cost	(1,861)
Payments towards debt	(110)	(17)
Proceeds from exercise of stock option	73	57
Proceeds from exercise of warrants	882
Proceeds from issuance of common stock		7
Purchase of common stock (withholding taxes)		(4)
Net cash provided by financing activities	68,984	43
Effect of exchange rates on cash and cash equivalents	30	(58)
Net increase (decrease) in cash and cash equivalents	34,648	(52,846)
Cash and cash equivalents at beginning of period	47,230	100,076
Cash and cash equivalents at end of period	81,878	47,230
Non-cash investing and financing activities
Common stock issued in acquisition of business		13,888
Capital expenditure included in Accrued expenses and other current liabilities	285	605
Reclassification of warrant liability to common stock warrants	1,248
Issuance of warrants	22,843
Interest paid in shares	1,888
Interest paid in cash	1,808
Income taxes paid, net	$ 147